Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.54 |
| ▸ | CNR2 | P34972 | 1/20 | 0.54 |
| ▸ | HRH1 | P35367 | 1/20 | 0.54 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.54 |
| ▸ | SCN2A | Q99250 | 4/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.47 |
| ▸ | HPGDS | O60760 | 3/20 | 0.45 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.44 |
| ▸ | CDK1 | P06493 | 1/20 | 0.44 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.44 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.44 |
| ▸ | SMPD3 | Q9NY59 | 1/20 | 0.44 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.44 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26095410 | 1.00 | CNR1 (0.54) | CNR1CNR2HRH1HRH4SCN2A | |
| SCHEMBL1179895 | 0.83 | SCN2A (0.56) | SCN2ANPY5RHPGDSSMPD3HSD17B1 | |
| SCHEMBL1181006 | 0.83 | SCN2A (0.56) | SCN2ANPY5RHPGDSCCNB2CDK1 | |
| SCHEMBL27832173 | 0.79 | NPY5R (0.63) | NPY5RHPGDSRIPK1 | |
| SCHEMBL31660384 | 0.79 | NPY5R (0.68) | CNR1CNR2HRH1HRH4SCN2A | |
| SCHEMBL21980361 | 0.79 | NPY5R (0.68) | CNR1CNR2HRH1HRH4SCN2A | |
| SCHEMBL19501567 | 0.76 | MASP2 (0.62) | CCNB2CDK1CCNB1CCNB3HSD17B1 | |
| SCHEMBL19443320 | 0.76 | SCN2A (0.49) | SCN2ANPY5RHPGDSCCNB2CDK1 | |
| SCHEMBL15425134 | 0.76 | SNCA (0.61) | CNR1CNR2HRH1HRH4SCN2A | |
| SCHEMBL8207447 | 0.75 | HSD17B1 (0.65) | HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250228242-A1 | PROTEIN AGGREGATION INHIBITING COMPOUNDS FOR PLANT DISEASE CONTROL | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2025-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250228242-A1 | PROTEIN AGGREGATION INHIBITING COMPOUNDS FOR PLANT DISEASE CONTROL | APP, APBA1, PRNP | CNR1 4327/4885CNR2 4645/4885HRH1 2691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.